Physician's Weekly

JUNE 17, 2025

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

Telehealth 52

Telehealth Relationship Hospital Appointment 52

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. More updates will follow here as trends develop in 2023. By John W.M. FDA has shown a willingness to intervene in this space.

Patient-Centered 59

Patient-Centered Manufacturing Provider Telehealth 59

FDA Law Blog

JUNE 21, 2023

telemedicine and telehealth solutions (e.g., What processes and medical procedures, including diagnostics, do you believe would be ideal for transitioning from a hospital and/or healthcare setting to non-clinical care settings, for example, home use or school/work use? and remote or wearable patient monitoring devices (e.g.,

Medical 45

Medical Patients Healthcare Electronics 45

GeriPal

JULY 20, 2023

This DEA is taking 6-months to consider how to move forward vis a vis restrictions and requirements for telehealth in a post-pandemic world. See the AAHPM Legislative Action Center [link] Write to the DEA, with guidance from AAHPM’s comments to the DEA March 2023. AlexSmithMD Transcript Eric: Welcome to the GeriPal podcast.

Telemedicine 73

Telemedicine Telehealth Patient-Centered Board-Certified 73